4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001628280-26-058920
SVP, General Counsel sold 29,697 shares at $2.12 ($62,958)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Douglas Earl Martin SVP, General Counsel | 2026-08-21 | Sale | −29,697 | $2.12 | $62,958 | 488,267 | D: show line 1 in the form |
| Open-market sales · 29,697 sh · avg $2.12 · $62,958 | |||||||
Loading xslF345X06/wk-form4_1787690594.xml…